Project outlines

Page updated on March 2nd, 2011

The EU Member States are concerned about the quality of health care and the possible inequalities among EU citizens. Coronary heart disease is very frequent in EU and is the origin of many admissions, patient management and procedure use.

EURHOBOP is a project funded by the European Commission ("Executive Agency for Health and Consumers"), under the Second Programme of Community Action in the Field of Public Health (2008–2013). It contributes to pursue the objective of “generating and disseminating health information and knowledge” and is based on the preliminary results obtained in the EUPHORIC (www.euphoric-project.eu) cardiovascular pilot study.

EURHOBOP seeks to provide European hospitals with a validated set of statistical functions - including determinants of in-hospital case fatality outcome indicator - to benchmark themselves about the quality of the management of myocardial infarction or unstable angina patients and in the use of the treatments aimed at removing the coronary artery occlusion.

Benchmarking the hospital performance is, in fact, a key instrument to improve the quality of health care.

In EUPHORIC (www.euphoric-project.eu) a set of functions predictive of EU Hospital performance in terms of management of coronary heart disease patients and some procedures used in their admission were successfully wound up. Under EURHOBOP the functions will be validated on real life data by enrolling a large number of hospitals and the possibility of including other variables of severity will be tested.

Patients admitted for an acute coronary syndrome in EU hospitals receive a discharge diagnosis of myocardial infarction (MI) either with or without Q-wave in the electrocardiogram, or unstable angina (UA). MI and UA are easy to identify and their management includes a number of procedures (Coronary angiography; Thrombolysis; Percutaneous intervention; General MI-UA patient management) available in many hospitals in Europe and already tracked by the existing monitoring systems.

EURHOBOP will consider as outcome the "in-hospital case-fatality after the procedure", a hard, standardized end-point that can be easily retrieved from medical records and administrative discharge records.

Hospitals will be requested to provide data of 200 consecutive patients with discharge diagnosis of MI or UA retrospectively recruited. Hospital enrollment will be carried out in two phases:

  1. through the already established network of the associated beneficiaries (10 hospitals per country, enrolled as Associated collaborating partners)
  2. opening the invitation to all the European hospitals (enrolled as Affiliated collaborating partners) 

The project is organized in the following 8 Work Packages:

WP 1: Coordination of the project (Jaume Marrugat, IMAS-IMIM)
WP 2: Dissemination of the results (Marina Torre, ISS)
WP 3: Evaluation of the project (Christa Meisinger, HMGU)
WP 4: Hospital benchmarking function development and validation (Jaume Marrugat, IMAS-IMIM)
WP 5: Analysis of the availability of severity measurements in administrative data (Jean Ferrières, AEPMCV)
WP 6: Gender inequalities assessment ("Effect modification by gender in outcome studies”) (Marina Davoli, DEASL)
WP 7: Cost analysis of procedures (Unto Häkkinen, THL)
WP 8: Benchmarking testing with hospital real life data (Pascal Garel, HOPE)

Click here to read the description of the 8 Work Packages

Timetable: The project started on 01/09/2009 and will end on 31/08/2012.